Access the full text.
Sign up today, get DeepDyve free for 14 days.
M. Rösel, C. Claas, S. Seiter, M. Herlevsen, M. Zöller (1998)
Cloning and functional characterization of a new phosphatidyl-inositol anchored molecule of a metastasizing rat pancreatic tumorOncogene, 17
Magnus Kjaergaard, L. Hansen, Benedikte Jacobsen, H. Gårdsvoll, M. Ploug (2008)
Structure and ligand interactions of the urokinase receptor (uPAR).Frontiers in bioscience : a journal and virtual library, 13
H. Gårdsvoll, L. Hansen, T. Jørgensen, M. Ploug (2007)
A new tagging system for production of recombinant proteins in Drosophila S2 cells using the third domain of the urokinase receptor.Protein expression and purification, 52 2
L. Hansen, H. Gårdsvoll, B. Nielsen, L. Lund, K. Danø, O. Jensen, M. Ploug (2004)
Structural analysis and tissue localization of human C4.4A: a protein homologue of the urokinase receptor.The Biochemical journal, 380 Pt 3
D1D2 domains of C4
M. Kriegbaum, O. Clausen, O. Lærum, M. Ploug (2015)
Expression of the Ly6/uPAR-Domain Proteins C4.4A and Haldisin in Non-Invasive and Invasive Skin LesionsJournal of Histochemistry & Cytochemistry, 63
M. Kriegbaum, Benedikte Jacobsen, Andreas Hald, M. Ploug (2011)
Expression of C4.4A, a Structural uPAR Homolog, Reflects Squamous Epithelial Differentiation in the Adult Mouse and during EmbryogenesisJournal of Histochemistry & Cytochemistry, 59
M. Ploug, Søren Østergaard, H. Gårdsvoll, Katherine Kovalski, Claus Holst-Hansen, Arne Holm, and Ossowski, K. Danø (2001)
Peptide-derived antagonists of the urokinase receptor. affinity maturation by combinatorial chemistry, identification of functional epitopes, and inhibitory effect on cancer cell intravasation.Biochemistry, 40 40
Masahisa Ohtsuka, Hirofumi Yamamoto, Ryota Oshiro, H. Takahashi, T. Masuzawa, M. Uemura, N. Haraguchi, J. Nishimura, T. Hata, M. Yamasaki, I. Takemasa, H. Miyata, T. Mizushima, S. Takiguchi, Y. Doki, M. Mori (2013)
Concurrent expression of C4.4A and Tenascin-C in tumor cells relates to poor prognosis of esophageal squamous cell carcinoma.International journal of oncology, 43 2
L. Hansen, O. Lærum, M. Illemann, B. Nielsen, M. Ploug (2008)
Altered expression of the urokinase receptor homologue, C4.4A, in invasive areas of human esophageal squamous cell carcinomaInternational Journal of Cancer, 122
M. Kriegbaum, Morten Persson, L. Haldager, W. Alpízar-Alpízar, B. Jacobsen, H. Gårdsvoll, A. Kjaer, M. Ploug (2011)
Rational targeting of the urokinase receptor (uPAR): development of antagonists and non-invasive imaging probes.Current drug targets, 12 12
Benedikte Jacobsen, M. Ploug (2008)
The urokinase receptor and its structural homologue C4.4A in human cancer: expression, prognosis and pharmacological inhibition.Current medicinal chemistry, 15 25
Barbara Smith, W. Kennedy, P. Harnden, P. Selby, L. Trejdosiewicz, J. Southgate (2001)
Identification of genes involved in human urothelial cell-matrix interactions: implications for the progression pathways of malignant urothelium.Cancer research, 61 4
(2010)
Cancer Sci
K. Konishi, Hirofumi Yamamoto, K. Mimori, I. Takemasa, T. Mizushima, M. Ikeda, M. Sekimoto, N. Matsuura, T. Takao, Y. Doki, M. Mori (2010)
Expression of C4.4A at the invasive front is a novel prognostic marker for disease recurrence of colorectal cancerCancer Science, 101
M. Ploug (2013)
Structure-Driven Design of Radionuclide Tracers for Non-Invasive Imaging of uPAR and Targeted Radiotherapy. The Tale of a Synthetic Peptide AntagonistTheranostics, 3
T. Miyake, Takashi Ito, Ayako Yanai, N. Inoue, Yoshimasa Miyagawa, K. Murase, M. Imamura, S. Ichii, Y. Takatsuka, T. Nishizaki, S. Hirota, Masahisa Ohtsuka, Hirofumi Yamamoto, S. Noguchi, Y. Miyoshi (2015)
C4.4A highly expressed in HER2-positive human breast cancers may indicate a good prognosisBreast Cancer, 22
Florian Thuma, Honoré Ngora, M. Zöller (2013)
The metastasis‐associated molecule C4.4A promotes tissue invasion and anchorage independence by associating with the alpha6beta4 integrinMolecular Oncology, 7
P. Llinas, Marie Du, H. Gårdsvoll, K. Danø, M. Ploug, B. Gilquin, E. Stura, A. Ménez (2005)
Crystal structure of the human urokinase plasminogen activator receptor bound to an antagonist peptideThe EMBO Journal, 24
M. Kriegbaum, Benedikte Jacobsen, A. Füchtbauer, G. Hansen, I. Christensen, C. Rundsten, Morten Persson, L. Engelholm, A. Madsen, I. Meo, I. Lund, B. Holst, A. Kjaer, O. Lærum, E. Füchtbauer, M. Ploug (2016)
C4.4A gene ablation is compatible with normal epidermal development and causes modest overt phenotypesScientific Reports, 6
L. Hansen, B. Skov, M. Ploug, H. Pappot (2007)
Tumour cell expression of C4.4A, a structural homologue of the urokinase receptor, correlates with poor prognosis in non-small cell lung cancer.Lung cancer, 58 2
C. Paret, D. Hildebrand, Jürgen Weitz, Annette Kopp-Schneider, A. Kuhn, A. Beer, R. Hautmann, Margot Zöller (2007)
C4.4A as a candidate marker in the diagnosis of colorectal cancerBritish Journal of Cancer, 97
G. Winter (2010)
xia2: an expert system for macromolecular crystallography data reductionJournal of Applied Crystallography, 43
Morten Persson, D. Skovgaard, M. Brandt-Larsen, C. Christensen, J. Madsen, C. Nielsen, T. Thurison, T. Klausen, S. Holm, A. Loft, A. Berthelsen, M. Ploug, H. Pappot, K. Brasso, N. Kroman, L. Højgaard, A. Kjaer (2015)
First-in-human uPAR PET: Imaging of Cancer AggressivenessTheranostics, 5
Benedikte Jacobsen, T. Muley, M. Meister, H. Dienemann, I. Christensen, E. Santoni-Rugiu, O. Lærum, M. Ploug (2013)
Ly6/uPAR-Related Protein C4.4A as a Marker of Solid Growth Pattern and Poor Prognosis in Lung AdenocarcinomaJournal of Thoracic Oncology, 8
H. Gårdsvoll, M. Kriegbaum, E. Hertz, W. Alpízar-Alpízar, M. Ploug (2013)
The Urokinase Receptor Homolog Haldisin Is a Novel Differentiation Marker of Stratum Granulosum in Squamous EpitheliaJournal of Histochemistry & Cytochemistry, 61
Benedikte Jacobsen, E. Santoni-Rugiu, M. Illemann, M. Kriegbaum, O. Lærum, M. Ploug (2012)
Expression of C4.4A in precursor lesions of pulmonary adenocarcinoma and squamous cell carcinomaInternational Journal of Cancer, 130
C4.4A is a glycosylphosphatidylinositol‐anchored membrane protein comprised of two LU domains (Ly6/uPAR‐like domains) and an extensively O‐glycosylated C‐terminal Ser/Thr/Pro‐rich region. C4.4A is a novel biomarker for squamous epithelial differentiation. Its expression is dysregulated under various pathological conditions and it is a robust biomarker for poor prognosis in various malignant conditions such as pulmonary adenocarcinoma. To facilitate crystallization, the two LU domains were excised from intact C4.4A by limited proteolysis, purified and crystallized by the sitting‐drop vapour‐diffusion method. The crystals diffracted to 2.7 Å resolution and belonged to space group C2221, with unit‐cell parameters a = 55.49, b = 119.63, c = 168.54 Å. The statistics indicated good quality of the data, which form a solid basis for the determination of the C4.4A structure.
Acta Crystallographica Section F Structural Biology Communications – Wiley
Published: Jan 1, 2017
Keywords: ; ; ;
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.